Previous 10 | Next 10 |
2024-05-08 16:42:28 ET More on Mind Medicine MindMed: Breakthrough Status From The FDA For LSD Therapy Mind Medicine: GAD Program Success Continues With BTD And Positive Treatment Data Mind Medicine (MindMed) Inc. (MNMD) Q4 2023 Earnings Call Transcript MindM...
--Announced positive Phase 2b clinical trial results for MM120 in Generalized Anxiety Disorder (GAD), demonstrating clinically and statistically significant activity through 12 weeks after treatment-- --The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation t...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
2024-05-07 17:35:59 ET Major earnings expected after the bell on Wednesday include: Energy Transfer LP ( ET ) Airbnb ( ABNB ) The Trade Desk ( TTD ) AMC Entertainment Holdings ( AMC ) Innovative Industrial Properties ( IIPR ) Read the full a...
2024-05-07 05:54:17 ET More on psychedelic therapies MindMed: Breakthrough Status From FDA For LSD Therapy COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way? Mind Medicine: GAD Program Success Continues With BTD MindMed releases promising data on LSD-...
2024-05-06 12:16:59 ET More on Mind Medicine MindMed: Breakthrough Status From The FDA For LSD Therapy Mind Medicine: GAD Program Success Continues With BTD And Positive Treatment Data Mind Medicine (MindMed) Inc. (MNMD) Q4 2023 Earnings Call Transcript Psych...
-A single oral administration of MM120 100 µg met its primary and key secondary endpoints and maintained clinically and statistically significant HAM-A reductions compared to placebo at 12 weeks with a 65% clinical response rate and a 48% clinical remission rate- -MindMed also presen...
A new study has disputed the common belief that experiencing trauma in one’s childhood may affect a user’s experience with ayahuasca. Ayahuasca is a psychoactive brew that has been used by Indigenous cultures in the Amazon and Orinoco basins for millennia for divination, spiritu...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on Wednesday, May 8, 2024, ...
News, Short Squeeze, Breakout and More Instantly...
Mind Medicine (MindMed) Inc. Company Name:
MNMD Stock Symbol:
NASDAQ Market:
Mind Medicine (MindMed) Inc. Website:
- New patent covers MM120 ODT formulation and extends patent term to 2041- - Claims include pharmaceutical formulation, methods of manufacturing and methods of treatment for MM120 ODT- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed...
Cluster headaches are headaches characterized by severe pain that often occurs on a side of the head or behind one eye. These headaches may last anywhere between 15 minutes to 3 hours and usually strike suddenly, often recurring more than once a day. The pain experienced by patients is... R...